CTRI/2020/11/029323尚未招募4 期
An Open Prospective Non Comparative Single centric Investigator Initiated Clinical Study to Evaluate the Efficacy and Safety of Mac Q10 Plus Fixed Dose Combination of Coenzyme Q10 200 mg Folic acid 400 mcg L arginine 3000 mg Levocarnitine 500 mg Lycopene 5 mg Pine bark extract 75 mg Tribulus terrestris extract 600 mg Withania somnifera extract 500 mg Sachet in Male Patients with Infertility
Dr Chaitanya Shembekar0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 4 期
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Pms
入排标准
入选标准
- •1.Clinically healthy infertile men, who have had a prior medical consultation and Patient between age of 20 and 45 years
- •2.Female Partner age less than 40
- •3.Having had regular sexual intercourse without contraception (male & female) for a year or more without achieving a pregnancy
- •4.Male patients consulting for primary or secondary infertility
- •5.All men must have either sperm concentration <15 million/ml or Motility is <32% morphological normal spermatozoa
- •6.Willingness to give their written informed consent to participate in the study
- •7.Patients willing to follow the procedures as per the study protocol and voluntarily sign an informed consent form
排除标准
- •1.Klinefelters syndrome
- •2.Hypogondotropic hypogonadism
- •3.Y-chromosome microdeletion or abnormality
- •4.Other genetic cause for infertility
- •5.Patients with Hydrocele, varicocele, epididymitis
- •6.Previously treated and cured testicular condition
- •7.Obstructive azoospermia
- •8.Partner with salpingitis
- •9.Partner with polycystic ovarian syndrome
- •10.Partner with disturbance of ovulation
- •11.Partner with endometriosis
- •12.History of cancer
- •13.History of treatment with cytotoxic drugs, irradiation, or sulfasalazopyrine
- •14.History of bilateral cryptorchidism
- •15.History of mumps orchitis
- •16.History of vasectomy
- •17.Patients showing having past history of high serum prolactin levels
- •18.Patients having documented history of having chronic, contagious infectious disease, such as active tuberculosis, Hepatitis B or C, or HIV
- •19.Leukocytospermia
- •20.Patients with past history Psychiatric disorder such as (schizophrenia, bipolar disorder) or substance-related disorder, Patients currently in psychotherapeutic or psychiatric therapy
- •21.Patients with past history of significant hepatopathy (liver enzymes elevated 2-3-fold higher than the normal range), Renal insufficiency (serum creatinine level >2.5 mg/dL)
- •22.History of hyperthyroidism or Hypothyroidism
- •23.Patients with known hypersensitivity to any of the study related drugs
- •24.Patients who are currently enrolled in another clinical investigation or have been enrolled in any infertility trial during the past 3 months
- •25.Any other condition that, in the opinion of the investigator, does not justify the inclusion of the subject in the study
研究者
相似试验
已完成
3 期
A clinical trial to study the effects of evaluation of efficacy and safety of Fermalac Intravaginal Capsule (Lactobacillus Rhamnosus, Lactobacillus Delbrueckii, Streptococcus Thermophilus) in the treatment of Bacterial Vaginosis among the Indian womeCTRI/2009/091/000919Arun & Co.603 / B Polaris, Off Marol Maroshi Road,Behind Sangeet Plaza, Marol,Andheri (East), Mumbai - 400059India200
已完成
4 期
A post marketing study to study the pharmacokinetic parameters of Factor VIII in patients with Haemophilia ACTRI/2009/091/000027Celestial Biologics Limited
尚未招募
4 期
A Study of Febuxostat Tablets for treatment of chronic HyperuricemiaCTRI/2018/10/016116Ajanta Pharma Ltd
进行中（未招募）
不适用
A 12-month research project for children who have gone through the FUTURE 5 research project and who want to continue treatment to see how well bosentan is tolerated when administered over a long period of time.Pulmonary arterial hypertension (PAH) in childrenMedDRA version: 14.1Level: LLTClassification code 10064908Term: Associated with (APAH)System Organ Class: 10038738 - Respiratory, thoracic and mediastinal disordersMedDRA version: 14.1Level: LLTClassification code 10064909Term: Idiopathic (IPAH)System Organ Class: 10038738 - Respiratory, thoracic and mediastinal disordersMedDRA version: 14.1Level: LLTClassification code 10064910Term: Familial (FPAH)System Organ Class: 10038738 - Respiratory, thoracic and mediastinal disordersEUCTR2011-004612-31-PTActelion pharmaceuticals Ltd105
进行中（未招募）
1 期
A 12-month research project for children who have gone through the FUTURE 5 research project and who want to continue treatment to see how well bosentan is tolerated when administered over a long period of time.Pulmonary arterial hypertension (PAH) in childrenMedDRA version: 14.1Level: LLTClassification code 10064908Term: Associated with (APAH)System Organ Class: 10038738 - Respiratory, thoracic and mediastinal disordersMedDRA version: 14.1Level: LLTClassification code 10064909Term: Idiopathic (IPAH)System Organ Class: 10038738 - Respiratory, thoracic and mediastinal disordersMedDRA version: 14.1Level: LLTClassification code 10064910Term: Familial (FPAH)System Organ Class: 10038738 - Respiratory, thoracic and mediastinal disordersEUCTR2011-004612-31-NLActelion pharmaceuticals Ltd105